Neuberg Sehgal Path Lab Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 242.64%
(FY 2023)
- Profit 155.82%
(FY 2023)
- Ebitda 245.96%
(FY 2023)
- Net Worth 252.53%
(FY 2023)
- Total Assets 137.03%
(FY 2023)
About Neuberg Sehgal Path Lab
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Athmanathan Ganesan, Aishwarya Sundeep, Kunal Sehgal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85100MH2021PTC368059
- Company No.
368059
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Sep 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Neuberg Sehgal Path Lab?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Athmanathan Ganesan  | Director | 13-Apr-2024 | Current |
| Aishwarya Sundeep | Director | 13-Apr-2024 | Current |
| Kunal Sehgal | Director | 23-Sep-2021 | Current |
| Sonal Sehgal | Director | 23-Sep-2021 | Current |
| Kavya Velu | Director | 27-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Neuberg Sehgal Path Lab.
Neuberg Sehgal Path Lab Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 242.64% increase. The company also saw a substantial improvement in profitability, with a 155.82% increase in profit. The company's net worth Soared by an impressive increase of 252.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neuberg Sehgal Path Lab?
Unlock access to Neuberg Sehgal Path Lab's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Neuberg Abha Laboratory Private LimitedActive 4 years 7 monthsAthmanathan Ganesan is a mutual person
Magnum Imaging & Diagnostics Private LimitedActive 11 years 2 monthsAthmanathan Ganesan and Kavya Velu are mutual person
Anand Diagnostic Laboratory Private LimitedActive 2 years 11 monthsAthmanathan Ganesan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neuberg Sehgal Path Lab?
Neuberg Sehgal Path Lab has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neuberg Sehgal Path Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuberg Sehgal Path Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
